• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Consonance Capital Partners Adds Ken Kim, MD, Jeffrey Le Benger, MD, Bill Lucia, and Eric Major to Advisory Board

    10/20/21 10:00:00 AM ET
    $ALHC
    $HMSY
    Medical Specialities
    Health Care
    Business Services
    Miscellaneous
    Get the next $ALHC alert in real time by email

    Top Health Care Business and Policy Leaders Enhance Position as One of the Leading Health Care Private Equity Firms

    Consonance Capital Partners, a leading U.S.-based healthcare private equity firm, today announced that it has added health care leaders Hyong (Ken) Kim, MD, Jeffrey Le Benger, MD, Bill Lucia, and Eric Major to its Operating Council and Senior Advisory Board. Consonance Capital Partners' Operating Council and Senior Advisory Board members work closely with the firm's investment professionals, bringing valuable market insights, helping to source and diligence deals, and advising portfolio company management teams and serving on their boards of directors.

    "We are thrilled to welcome Ken, Jeffrey and Bill to our Operating Council and Eric to our Advisory Board. Their experience as health care business and policy leaders increases the impact of our efforts to partner with world-class management teams who are running great health care businesses that provide high-quality care and services, and will enhance the results of our partnerships," said the firm's four managing partners and co-founders, Mitchell Blutt, Benjamin Edmands, Stephen McKenna, and Nancy-Ann DeParle. "They are joining other transformational health care leaders already serving on our Operating Council and Senior Advisory Board."

    • Hyong (Ken) Kim, MD, is the former Chief Medical Officer of the Center for Medicare and Medicaid Innovation (CMMI) of the U.S. Centers for Medicare and Medicaid Services (CMS), where he advised in all payment and clinical model development, including for demonstrations of direct contracting, bundled payment, primary care first, and risk adjustment models. At CMMI, Dr. Kim also chaired the Quality Improvement Council and created operational pathways for performance reviews for all 36 CMMI models. From 2013-2018, Dr. Kim was co-founder and Chief Medical Officer of Alignment Healthcare (NASDAQ:ALHC), where he built and managed Alignment's clinical and operations team, developed its clinical model, and implemented an in-house, AI-enabled clinical data analytics platform and mobile app. Board-certified in internal medicine, from 1999-2013, Dr. Kim held various roles at CareMore Health, starting as a hospitalist and ultimately serving as Chief Medical Officer from 2009-2013.
    • Jeffrey Le Benger, MD, FACS, is Executive Chairman of the board that governs Summit Health, the health care network formed by the 2019 merger of Summit Medical Group and CityMD. A Consonance Capital Partners portfolio company, Summit Health offers high-quality primary, specialty, and urgent care through more than 2000 providers, 9000 employees, and 200 locations in New Jersey, New York, and Central Oregon. Before becoming Executive Chairman in October 2021, Dr. Le Benger served as chief executive officer of Summit Medical Group since 1999 and of Summit Health since 2019. He led Summit Medical Group, one of the nation's premier independent physician-driven multispecialty medical groups, through its successful merger with CityMD, the leading urgent care provider in the New York metro area. A thought leader in physician group practice management, value-based care, and population health management, Dr. Le Benger is board-certified in otolaryngology, head and neck surgery, and facial plastic and reconstructive surgery, and is a Fellow of the American College of Surgeons.
    • Bill Lucia is the former chairman, president, and chief executive officer of HMS Holdings Corp (NASDAQ:HMSY), a leading healthcare analytics and technology company. Under Mr. Lucia's leadership, HMS grew to $673 million in revenue, serving 500 healthcare payors and 50 government agencies in more than 40 States. Before becoming CEO, Mr. Lucia served as HMS' president and chief operating officer, and held leadership positions in the life insurance industry, serving as senior vice president, operations, and chief information officer for Celtic Life Insurance Company. He serves as a director of Consonance Capital Partners' portfolio company Sellers Dorsey, a leading Medicaid finance, strategy, and consulting firm. He also serves on the Steering Committee for the IMPAC Fund, a group of business leaders dedicated to finding bipartisan solutions on immigration reform, and on the International Advisory Board for ANDHealth, a digital health incubator based in Australia.
    • Eric Major is the former President of Stryker Spine, which he joined as part of its 2018 acquisition of K2M Group Holdings, Inc. (NASDAQ:KTWO), a medical device company he founded in 2004 to address the world's most challenging spinal pathologies. Under his leadership, K2M grew into a publicly traded global leader serving patients in over 40 countries during the company's 14 straight years of uninterrupted revenue growth. Prior to founding K2M, Mr. Major founded and served as the President & CEO of American OsteoMedix, Inc. ("AOM"), a pioneering minimally invasive spinal device company that was acquired by Interpore Cross International in 2001. Eric is an active member of the medical device industry and has served on the Board of Directors of the Medical Device Manufacturers Association (MDMA), as well as the AdvaMed CEO Advisory Council.

    About Consonance Capital Partners

    Consonance Capital Partners invests in private companies in the lower and middle markets of the U.S. healthcare industry, with an emphasis on businesses driving efficiency, cost containment, and high-quality care to patients. Consonance Capital Partners participates in growth equity, leveraged buyout, carve-out, recapitalization, and special situation transactions. For more information, visit www.consonancecapitalpartners.com

    View source version on businesswire.com: https://www.businesswire.com/news/home/20211020005707/en/

    Get the next $ALHC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALHC
    $HMSY

    CompanyDatePrice TargetRatingAnalyst
    Alignment Healthcare Inc.
    $ALHC
    4/17/2026$24.00Outperform
    Wolfe Research
    Alignment Healthcare Inc.
    $ALHC
    11/24/2025$20.00Neutral → Overweight
    Analyst
    Alignment Healthcare Inc.
    $ALHC
    10/14/2025$21.00Buy
    Goldman
    Alignment Healthcare Inc.
    $ALHC
    8/25/2025$21.00Sector Weight → Overweight
    KeyBanc Capital Markets
    Alignment Healthcare Inc.
    $ALHC
    7/31/2025$13.00Underweight → Equal Weight
    Barclays
    Alignment Healthcare Inc.
    $ALHC
    12/3/2024$13.00 → $17.00Equal-Weight → Overweight
    Stephens
    Alignment Healthcare Inc.
    $ALHC
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    Alignment Healthcare Inc.
    $ALHC
    5/30/2024$10.00Outperform
    Robert W. Baird
    More analyst ratings

    $ALHC
    $HMSY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Kao John E bought $496,779 worth of shares (103,000 units at $4.82), increasing direct ownership by 4% to 2,745,253 units (SEC Form 4)

    4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    3/18/24 5:27:36 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    $HMSY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wolfe Research initiated coverage on Alignment Healthcare with a new price target

    Wolfe Research initiated coverage of Alignment Healthcare with a rating of Outperform and set a new price target of $24.00

    4/17/26 8:10:24 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare upgraded by Analyst with a new price target

    Analyst upgraded Alignment Healthcare from Neutral to Overweight and set a new price target of $20.00

    11/24/25 8:06:33 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Goldman initiated coverage on Alignment Healthcare with a new price target

    Goldman initiated coverage of Alignment Healthcare with a rating of Buy and set a new price target of $21.00

    10/14/25 8:46:39 AM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    $HMSY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Alignment Healthcare to Announce First Quarter 2026 Financial Results and Host Conference Call Thursday, April 30, 2026

    ORANGE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), will release its first quarter 2026 financial results on Thursday, April 30, 2026, after market close. Following the release, the company will host a conference call to review its financial results at 5 p.m. EDT. Conference Call DetailsA live audio webcast will be available online at https://ir.alignmenthealth.com/. At the start of the conference call, participants may access the webcast at the following link: https://edge.media-server.com/mmc/p/53zw9jkh A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call at the same web links and w

    4/9/26 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare to Present at the BofA Securities Health Care Conference 2026

    ORANGE, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), today announced that it will present at the BofA Securities Health Care Conference 2026 in Las Vegas on Wednesday, May 13, at 8:40 a.m. PDT. A webcast and replay of the presentation will be available on Alignment's investor relations website at https://ir.alignmenthealth.com/. About Alignment HealthcareAlignment Health is championing a new path in senior care that empowers members to age well and live their most vibrant lives. A consumer brand name of Alignment Healthcare (NASDAQ:ALHC), Alignment Health's mission-focused team makes high-quality, low-cost care a reality for its Medicare Advantage

    4/1/26 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare Announces Pricing of Secondary Offering

    ORANGE, Calif., March 02, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) ("Alignment Healthcare" or the "Company"), an award-winning Medicare Advantage (MA) company, today announced the pricing of its previously announced underwritten public offering of 13,167,733 shares of its common stock by an affiliate of General Atlantic, L.P (the "Selling Stockholder"). The underwriter sold the shares at a public offering price of $19.46 per share. The Company will not receive any of the proceeds from the sale of the shares of its common stock being offered by the Selling Stockholder. The offering is expected to close on March 4, 2026, subject to customary closing conditions. J.P.

    3/2/26 9:05:00 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    $HMSY
    SEC Filings

    View All

    SEC Form 144 filed by Alignment Healthcare Inc.

    144 - Alignment Healthcare, Inc. (0001832466) (Subject)

    4/7/26 4:27:55 PM ET
    $ALHC
    Medical Specialities
    Health Care

    SEC Form 144 filed by Alignment Healthcare Inc.

    144 - Alignment Healthcare, Inc. (0001832466) (Subject)

    4/1/26 4:46:35 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Alignment Healthcare Inc.

    SCHEDULE 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    3/26/26 3:24:13 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    $HMSY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Maroney Dawn Christine

    4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    4/15/26 8:41:33 PM ET
    $ALHC
    Medical Specialities
    Health Care

    SEC Form 4 filed by Kao John E

    4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    4/13/26 6:37:52 PM ET
    $ALHC
    Medical Specialities
    Health Care

    SEC Form 4 filed by Head James M

    4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    4/8/26 5:51:12 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    $HMSY
    Leadership Updates

    Live Leadership Updates

    View All

    Alignment Health Appoints Adnan Mansour as Chief Digital Officer to Accelerate AI-Driven Growth and Technology Leadership

    ORANGE, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Alignment Health, an award-winning Medicare Advantage (MA) company, today announced the appointment of Adnan Mansour as chief digital officer, an executive leadership role that unifies the company's technology and information functions to drive scalable growth and continued innovation. Mansour, formerly senior vice president and chief information officer at Optum Insight – the data, analytics and managed services division of UnitedHealth Group – brings decades of experience leading global IT and engineering teams and embedding artificial intelligence (AI) into complex health care systems. Effective Jan. 19, Mansour reports to Alignment Hea

    1/20/26 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare Names Matt Eyles Executive Vice President of Government & Business Strategy

    ORANGE, Calif., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) today announced that Matt Eyles will join as executive vice president of government and business strategy, effective Sept. 29. In this newly created position, Eyles will report directly to Alignment founder and CEO John Kao, elevating Alignment's engagement and leadership in health care policy at federal and state levels, leading innovative business planning to anticipate changes in the health care environment to drive growth, and developing new initiatives and partnerships aligned with enterprise priorities. "With Alignment's growing influence and impact, Matt's appointment comes at exactly the ri

    9/8/25 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare Founder and CEO John Kao Named to AHIP Board

    ORANGE, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) announced today that founder and CEO John Kao was elected to the AHIP board of directors, effective June 5, 2025. AHIP is a national business organization whose member companies provide health care coverage, services and solutions to millions of Americans every day. "I'm honored to join the AHIP board and collaborate with leaders across the industry who are committed to making health care work better for more Americans," said Kao. "The industry is at a critical inflection point, and I look forward to working with my fellow board members to help shape a stronger, more sustainable future for everyone

    6/10/25 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    $HMSY
    Financials

    Live finance-specific insights

    View All

    Alignment Healthcare to Announce First Quarter 2026 Financial Results and Host Conference Call Thursday, April 30, 2026

    ORANGE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), will release its first quarter 2026 financial results on Thursday, April 30, 2026, after market close. Following the release, the company will host a conference call to review its financial results at 5 p.m. EDT. Conference Call DetailsA live audio webcast will be available online at https://ir.alignmenthealth.com/. At the start of the conference call, participants may access the webcast at the following link: https://edge.media-server.com/mmc/p/53zw9jkh A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call at the same web links and w

    4/9/26 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics

    Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted gross profit and adjusted EBITDARaises health plan membership guidance by 2,000 at the midpoint and introduces 2026 revenue guidance of $5.14 billion to $5.19 billion, representing 30%-31% growth year-over-year, and adjusted EBITDA of $133 million to $163 millionEarns recognition on the 2026 Fortune World's Most Admired Companies™ list, underscoring the company's innovative approach to senior health care ORANGE, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC),

    2/26/26 4:01:00 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare to Announce Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call Thursday, Feb. 26, 2026

    ORANGE, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), will release its fourth quarter and full-year 2025 financial results on Thursday, Feb. 26, 2026, after market close. Following the release, the company will host a conference call to review its financial results at 5 p.m. EST. Conference Call DetailsA live audio webcast will be available online at https://ir.alignmenthealth.com/. At the start of the conference call, participants may access the webcast at the following link: https://edge.media-server.com/mmc/p/kd529mia A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call at the same we

    2/5/26 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    $HMSY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

    SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    11/14/24 5:57:27 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

    SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    11/14/24 1:28:35 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

    SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    11/12/24 1:26:14 PM ET
    $ALHC
    Medical Specialities
    Health Care